LIVANOVA PLC
NASDAQ: LIVN (LivaNova PLC)
Last update: 23 hours ago80.90
-0.37 (-0.46%)
| Previous Close | 81.27 |
| Open | 80.72 |
| Volume | 572,060 |
| Avg. Volume (3M) | 648,782 |
| Market Cap | 4,444,123,136 |
| Price / Earnings (TTM) | 23.93 |
| Price / Earnings (Forward) | 16.00 |
| Price / Sales | 2.93 |
| Price / Book | 3.23 |
| 52 Weeks Range | |
| Earnings Date | 4 Nov 2026 |
| Profit Margin | -17.42% |
| Operating Margin (TTM) | 15.54% |
| Diluted EPS (TTM) | -4.07 |
| Quarterly Revenue Growth (YOY) | 7.40% |
| Quarterly Earnings Growth (YOY) | 242.10% |
| Total Debt/Equity (MRQ) | 65.54% |
| Current Ratio (MRQ) | 1.58 |
| Operating Cash Flow (TTM) | 197.02 M |
| Levered Free Cash Flow (TTM) | 782.12 M |
| Return on Assets (TTM) | 4.55% |
| Return on Equity (TTM) | -19.70% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | LivaNova PLC | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -1.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Relative Valuation | 5.0 |
| Financial Health | NA |
| AI Insight | NA |
| Weighted Average | 2.14 |
Select this tab to load the latest available analysis.
|
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 0.38% |
| % Held by Institutions | 102.95% |
No data within this time range.
AI Technical Analysis
Open the Technical tab to generate the latest analysis.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |